1. Home
  2. CSTL vs PRSU Comparison

CSTL vs PRSU Comparison

Compare CSTL & PRSU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$29.72

Market Cap

940.8M

Sector

Health Care

ML Signal

HOLD

Logo Pursuit Attractions and Hospitality Inc.

PRSU

Pursuit Attractions and Hospitality Inc.

HOLD

Current Price

$34.29

Market Cap

946.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTL
PRSU
Founded
2007
1926
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
940.8M
946.6M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
CSTL
PRSU
Price
$29.72
$34.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$46.67
$31.67
AVG Volume (30 Days)
390.1K
186.3K
Earning Date
05-18-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$344,229,000.00
N/A
Revenue This Year
$3.15
$26.24
Revenue Next Year
N/A
$6.25
P/E Ratio
N/A
$3.45
Revenue Growth
3.66
N/A
52 Week Low
$14.59
$26.90
52 Week High
$44.28
$39.93

Technical Indicators

Market Signals
Indicator
CSTL
PRSU
Relative Strength Index (RSI) 33.66 40.49
Support Level $21.77 $34.17
Resistance Level $34.97 $37.75
Average True Range (ATR) 1.71 1.25
MACD -0.10 -0.29
Stochastic Oscillator 31.72 36.20

Price Performance

Historical Comparison
CSTL
PRSU

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

About PRSU Pursuit Attractions and Hospitality Inc.

Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, and Iceland. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.

Share on Social Networks: